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Abstract
Smoking is a modifiable risk factor for age-related macu-
lar degeneration (AMD), the leading cause of irreversible 
vision loss in the United States. We conducted a pilot 
study among eye care providers and AMD patients to 
assess smoking cessation preferences and cessation ser-
vices offered at a large academic medical center. Most 
patients who smoke reported never being advised to quit 
smoking, although most eye care providers reported that 
they had advised smokers to quit. Two-thirds of providers 
expressed a desire for additional training and resources 
to support patient quit attempts, indicating the need for 
the integration of smoking cessation opportunities in the 
clinic setting.
Objective
In the United States, age-related macular degeneration 
(AMD) is the leading cause of severe and irreversible 
vision loss, affecting more than 9.1 million people. Because 
of the increasing number of older people in the US popula-
tion, this number is expected to increase to 17.8 million 
by 2050 (1). Treatment options for “dry” AMD (eg, loss of 
retinal pigment and photoreceptors in the central part of 
the eye) are limited; therefore, addressing the few modifi-
able risk factors of AMD such as smoking is important 
(2). Little is known about the level of smoking cessation 
services offered to patients who smoke and who are being 
treated for AMD and the smoking cessation preferences of 
these patients (2). The purpose of this pilot study was to 
assess tobacco use and smoking cessation preferences of 
AMD patients and level and preference of smoking cessa-
tion services offered by their eye care providers at a large 
academic medical center.
Methods
The institutional review board at the University of Miami 
approved this pilot study. In June 2009, we sent clini-
cal faculty, fellows, and residents at the Bascom Palmer 
Eye Institute (BPEI) an e-mail message (and 1 follow-up 
reminder), extending an invitation to participate in a brief, 
anonymous Web-based, 16-item survey (SurveyMonkey, 
Palo Alto, California). We used a modified question 
set obtained from the Association of American Medical 
Colleges’ national smoking cessation survey of primary 
health care providers (3). The survey inquired about 
awareness and clinical practice of treating patients who 
smoke, specific eye care provider medical training, and 
provider sociodemographic characteristics.
During the same time, study team interviewers approached 
AMD patients who were visiting a BPEI retinal clinic in 
the patient waiting area to explain study objectives, 
assess interest in participating, and obtain verbal con-
sent. Inclusionary participant criteria included having 
a diagnosis of AMD, being aged 18 years or older, and 
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being fluent in English or Spanish. Interviewers admin-
istered an anonymous, language-sensitive (English or 
Spanish), 43-item paper questionnaire developed on the 
basis of standard tobacco use questions from the Centers 
for Disease Control and Prevention’s Behavioral Risk 
Factor Surveillance System survey and the Tobacco Use 
Supplement of the National Cancer Institute’s Current 
Population Survey, as well as selected study-specific 
vision health and eye disease questions (4,5). No partici-
pant incentives were provided. Analyses were performed 
using Predictive Analytics Software (SPSS, Inc, Chicago, 
Illinois) version 18.0.
Results
Eye care provider responses
The response rate for the eye care provider questionnaire 
was 51% (46 of 90). Forty-six percent of providers were 
women, 65% were faculty members, 17% were fellows, 
and 17% were residents; the most common age group was 
30 to 39 years. Most eye care providers indicated that 
they seldom or periodically asked about their patients’ 
smoking status, assessed their willingness to quit, and 
advised them to quit smoking (Table 1). The proportion of 
providers who indicated that they always engaged in these 
activities ranged from 7% to 28%. Eye care providers were 
aware that individual counseling for smoking cessation 
was available at the institution (94%) but were less aware 
that group counseling (7%) and multilingual resources 
were available (13%) (Table 2). Most eye care providers 
indicated that they would recommend these services if 
readily available in the clinic.
When prompted to identify which smoking cessation train-
ing or information the eye care provider would like to use, 
46% wanted training on how to select self-help materials 
to give their patients and 39% wanted to learn how to 
provide social support to their patients as part of their ces-
sation treatment. Most eye care providers indicated that 
their medical school education did not provide adequate 
training to effectively provide smoking cessation assis-
tance to their patients (65%).
Patient responses
The response rate for the AMD patient questionnaire 
was 100% (52 of 52). Respondents’ age ranged from 52 to 
97 years (mean age, 81 y). Forty-eight respondents were 
white and 4 were black; 22 reported Hispanic ethnicity. 
Of respondents, 19 had a high school diploma or less, and 
51 reported some type of health care insurance coverage. 
More than half of patients (54%) were not certain whether 
smoking causes macular degeneration or severe visual 
impairment, and 17% were smokers who, on average, vis-
ited an ophthalmologist 5 times per year. Nearly 90% of 
smokers reported never being advised to quit by their eye 
care provider, although two-thirds (n = 6) reported that 
they were seriously considering quitting smoking in the 
next 6 months.
Discussion
Epidemiologic evidence strongly suggests a causal rela-
tionship between smoking and the development of AMD 
(6). We found that a large proportion of AMD clinic 
patients were unaware of the link between smoking and 
eye disease. Eye care providers were interested in provid-
ing more smoking cessation services for their patients who 
smoke but generally reported lacking appropriate train-
ing, which indicates that opportunities exist for enhanc-
ing eye care and medical training curricula. Emerging 
evidence indicates that the risk of tobacco use–related 
eye diseases decreases substantially after smoking cessa-
tion, as suggested by the Rotterdam Study and from other 
scientific review articles (7-9). Therefore, enhancement of 
smoking cessation efforts among AMD patients should be 
considered an ocular-health priority, although the provi-
sion of such services should be offered to all clinic patients, 
given the overall deleterious health effects of continued 
smoking (10).
The sample size of this pilot study was small; administra-
tion of the eye care provider and patient questionnaires 
across a more representative sample of private practice 
and tertiary eye care clinics may provide additional 
insight into factors that influence the awareness and atti-
tudes of patients and eye care providers in smoking ces-
sation efforts. Finally, eye care provider survey response 
rates were slightly lower than those observed in national 
surveys of health care providers (11).
In conclusion, this study documented that both clinicians 
and their patients with AMD who smoke expressed a 
desire to facilitate and initiate quit attempts. Addiction to 
tobacco is increasingly considered to be a chronic condition 
often characterized by repeated attempts to maintain long-
term abstinence (1,2). System-based approaches in which 
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comprehensive smoking cessation services (eg, telephone 
quitlines) are embedded in integrated patient-care models 
have shown promising results (3), yet such a comprehen-
sive program has yet to be established and validated in an 
ocular clinic setting. Development of such a program in 
the context of the setting of busy eye care providers will 
not only help create awareness of the relationship between 
smoking and ocular disease risk but may also reduce the 
overall burden of tobacco use–associated disease in this 
high-risk population.
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Tables
Table 1. Prevalence of Eye Care Providers’ (n = 46) Smoking Status Assessment, Cessation Advice, and Treatment Practices, Florida, 
2009
Smoking Intervention Question
Reported Frequency of Activity
Always, na (%)
Periodically/ 
Seldom, na (%) Never, na (%)
Ask about smoking status 6 (1) 7 (80)  (7)
Assess patient willingness to quit smoking  (7) 5 (76) 8 (17)
Advise patients to stop smoking 1 (28) 0 (65)  (7)
Refer patients who smoke to other providers for cessation 0 27 (59) 19 (41)
Recommend nicotine replacement therapy 0 2 (50) 2 (50)
Prescribe other medication 0  (7) 4 (94)
Provide brochures/self-help materials 0  (7) 4 (94)
Arrange follow-up visits with patient to address smoking 0 7 (15) 9 (85)
Monitor patient progress in attempting to quit  (7) 16 (5) 27 (59)
 
a Differences in subtotal population sample due to item nonresponse or missing.
Table 2. Providers’ Awareness of Smoking Cessation Resources Available at Their Institution, Florida, 2009
Smoking Cessation Resource Available in Clinic, na (%) Would Use if Available, na (%)
Individual counseling 4 (94) 4 (94)
Group programs  (7) 28 (61)
Multilingual resources 6 (1) 29 (6)
Web-based smoking cessation programs 4 (9) 29 (6)
 
a Differences in subtotal population sample due to item nonresponse or missing.
